Brussels, Tuesday September 24, 2019, 08h30 CEST --- According to Belgian transparency legislation (Law of May 2, 2007), BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.) has notified Solvay S.A. that:

  • On September 17, 2019 BlackRock Inc. crossed upwards the 3% statutory threshold for direct voting rights, holding 3.03%. Including equivalent financial instruments, the total voting rights stood at 3.51%.
  • On September 18, 2019 BlackRock Inc. crossed downwards the 3% statutory threshold for direct voting rights, holding 2.80%. Including equivalent financial instruments, the total voting rights stood at 3.28%.

Declarations by BlackRock Inc. are published in the Investor Relations Section of Solvay's website.

Solvay is an advanced materials and specialty chemicals company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers worldwide in many diverse end-markets. Its products are used in planes, cars, batteries, smart and medical devices, as well as in mineral and oil and gas extraction, enhancing efficiency and sustainability. Its lightweighting materials promote cleaner mobility, its formulations optimize the use of resources, and its performance chemicals improve air and water quality.

Solvay is headquartered in Brussels with around 24,500 employees in 62 countries. Net sales were €10.3 billion in 2018, with 90% from activities where Solvay ranks among the world’s top 3 leaders, resulting in an EBITDA margin of 22%. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris (Bloomberg: SOLB.BB - Reuters: SOLB.BR), and in the United States its shares (SOLVY) are traded through a level-1 ADR program.

Figures take into account the planned divestment of Polyamides.